Cargando…
Further discussion on glucocorticoid treatment of COVID-19
Autores principales: | Feng, Yun’ai, Li, Haichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433069/ https://www.ncbi.nlm.nih.gov/pubmed/36044381 http://dx.doi.org/10.1097/CM9.0000000000001872 |
Ejemplares similares
-
Middle East Respiratory Syndrome and Blood Donation: Topic for Further Study and Discussion
por: Wiwanitkit, Viroj
Publicado: (2014) -
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020) -
Furthering patient adherence: A position paper of the international expert forum on patient adherence based on an internet forum discussion
por: van Dulmen, Sandra, et al.
Publicado: (2008) -
Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure()
por: Kow, C.S., et al.
Publicado: (2022) -
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
por: Isidori, Andrea M, et al.
Publicado: (2020)